At a glance
- Originator Nonindustrial source
- Class Antibacterials; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 20 Oct 1999 New profile
- 20 Oct 1999 Preclinical development for Staphylococcal infections in Japan (Unknown route)